SPARTHA MEDICAL
LIVE

Serial Number

79367129

Owner

SPARTHA MEDICAL

Attorney

Pina Campagna

Filing Date

Jan 27, 2023

Add to watchlist:

No watchlists yet
View on USPTO

SPARTHA MEDICAL Trademark

Serial Number: 79367129 • Registration: 7574638

SPARTHA MEDICAL is a trademark filed by SPARTHA MEDICAL on January 27, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

SPARTHA MEDICAL (3 trademarks)

2 rue Marie Hamm

Entity Type: 34

Trademark Details

Filing Date

January 27, 2023

Registration Date

November 26, 2024

Published for Opposition

June 25, 2024

Goods & Services

[ Surgical apparatus and instruments for medical, dental and veterinary use; ] applicators for antibacterial, antimicrobial and antiviral preparations in the nature of vaporizers for medical use; applicators for antiseptic preparations in the nature of vaporizers for medical use; applicators for anti-inflammatory preparations in the nature of vaporizers for medical use; [ nebulizers for medical use; ] vaporizers for medical use; [ suture materials; prostheses, namely, hip prostheses, shoulder prostheses, breast prostheses, dental prostheses, bone prostheses, facial prostheses, mandibular prostheses, and joint prostheses; artificial implants, namely, implants consisting of artificial materials; medical, surgical and orthopaedic implants consisting of artificial materials; fixation implants consisting of artificial material; orthopedic joint implants consisting of artificial materials; bone implants consisting of artificial materials; facial implants consisting of artificial materials; mandibular implants consisting of artificial materials; ocular implants consisting of artificial materials; dental implants consisting of artificial materials, and implants consisting primarily of artificial materials; special furniture for medical use; sterile surgical sheets; clothing especially for operating rooms; surgical masks and sanitary masks ]

Designing and developing biocidal, microbicidal, virucidal, bactericidal and germicidal solutions and coatings customized for the benefit of third parties; designing and developing anti-inflammatory coatings and solutions for the benefit of third parties; designing and developing antibacterial, antimicrobial and antiviral preparations for the benefit of third parties; designing and developing medical devices for the benefit of third parties; scientific, biological and laboratory analysis services in the field of biocidal, microbicidal, virucidal, bactericidal and germicidal coatings, microbiostatic and microbicidal materials, chemicals, biomedicine, microbiology, bacteriology, biotechnology, biomaterials and biopolymers, medical devices, prostheses and artificial implants, and coating technologies; laboratory services for medical research; scientific and technological services, namely, research and design services relating to biocidal, microbicidal, virucidal, bactericidal and germicidal coatings, microbiostatic and microbicidal materials, chemicals, biomedicine, microbiology, bacteriology, biotechnology, biomaterials and biopolymers, medical devices, prostheses and artificial implants, and coating technologies; scientific and technological research in the field of biocidal, microbicidal, virucidal, bactericidal and germicidal coatings, microbiostatic and microbicidal materials, chemicals, biomedicine, microbiology, bacteriology, biotechnology, biomaterials and biopolymers, medical devices, prostheses and artificial implants, and coating technologies; biological research; research in the field of physics; bacteriological research; chemical research; medical research; design, research and development of new products for others; engineering services in the field of biocidal, microbicidal, virucidal, bactericidal and germicidal coatings, microbiostatic and microbicidal materials, chemicals, biomedicine, microbiology, bacteriology, biotechnology, biomaterials and biopolymers, medical devices, prostheses and artificial implants, and coating technologies; engineering services in the field of polymeric compounds, polymer synthesis, and materials customization for medical, hygienical, scientific, and technological applications; technical project studies, namely, conducting of feasibility studies in the field of biocidal, microbicidal, virucidal, bactericidal and germicidal coatings, microbiostatic and microbicidal materials, chemicals, biomedicine, microbiology, bacteriology, biotechnology, biomaterials and biopolymers, medical devices, prostheses and artificial implants, and coating technologies; evaluations and assessments in the fields of science and technology provided by engineers; scientific and technical design, research, studies, analyses and surveys, in particular in the fields of health, treatments against microbes, germs, viruses and bacteria and artificial intelligence technologies; technological consultancy services in the field of biocidal, microbicidal, virucidal, bactericidal and germicidal coatings, microbiostatic and microbicidal materials, chemicals, biomedicine, microbiology, bacteriology, biotechnology, biomaterials and biopolymers, medical devices, prostheses and artificial implants, and coating technologies; industrial analysis and research services, in the field of biocidal, microbicidal, virucidal, bactericidal and germicidal coatings, microbiostatic and microbicidal materials, chemicals, biomedicine, microbiology, bacteriology, biotechnology, biomaterials and biopolymers, medical devices, prostheses and artificial implants, and coating technologies; industrial testing services in the field of biocidal, microbicidal, virucidal, bactericidal and germicidal coatings, microbiostatic and microbicidal materials, chemicals, biomedicine, microbiology, bacteriology, biotechnology, biomaterials and biopolymers, medical devices, prostheses and artificial implants, and coating technologies; testing of materials; laboratory testing services in the nature of medical laboratory services and scientific laboratory services; medical and scientific research, namely, conducting clinical trials for others; cell culture services for scientific research purposes, for others; design, development, installation, updating, maintenance, rental and temporary provision of online artificial intelligence computer software for the development of customized medical devices and biocidal, microbicidal, virucidal, bactericidal, germicidal, anti-inflammatory solutions and coatings; software as a service (SaaS) and platform as a service (PaaS) featuring software and computer software platforms for processing and analyzing data and images and developing customized medical devices and biocidal, microbicidal, virucidal, bactericidal, germicidal, anti-inflammatory solutions and coatings

Made-to-order manufacturing and custom manufacturing of biocidal, microbicidal, virucidal, bactericidal and germicidal coatings and solutions for the benefit of third parties; made-to-order manufacturing and custom manufacturing of anti-inflammatory coatings and solutions for the benefit of third parties; made-to-order manufacturing and custom manufacturing of antibacterial, antimicrobial and antiviral preparations * in the nature of coatings and solutions * for the benefit of third parties; [ made-to-order manufacturing and custom manufacturing of medical devices for the benefit of third parties; ] treatment of materials, namely, the addition of biosynthetic polymers to materials to make them bacteriostatic and bactericidal against bacteriological infections; treatment of materials, namely, metallic, polymer, electronic, plastic, silicone, ceramic or glass, paper, cardboard, rubber or textile materials, components and packaging by adding antimicrobial agents to protect against microbes, germs, viruses and bacteria; antimicrobial treatment of medical, surgical, dental and veterinary instruments and equipment against microbes, germs, viruses and bacteria; [ treatment of materials, namely, the addition of polymer additives and antimicrobial agents to materials used to manufacture medical devices, prostheses and artificial implants against microbes, germs, viruses and bacteria; antimicrobial treatment of medical devices, prostheses and artificial implants against microbes, germs, viruses and bacteria; anti-microbial treatment of electronic, optical, audiovisual, photographic equipment, computer hardware, data processing hardware, virtual or augmented reality hardware, helmets, head-mounted displays, gloves and 3D glasses, telecommunications apparatus, control devices, control apparatus for games and toys to protect against microbes, germs, viruses and bacteria; treatment and coating of metal surfaces; application of surface coatings to machines and tools for protective purposes by means of chemical, mechanical, thermal, thermo-mechanical, chemical vapor deposition, physical vapor deposition and vacuum deposition or by dipping processes in a solution; coating of eyeglasses and optical lenses for protective purposes by means of chemical, mechanical, thermal, thermo-mechanical, chemical vapor deposition, physical vapor deposition and vacuum deposition or by dipping processes in a solution; application of thin film coating for optical components; treatment of materials using chemicals; ] application of thin films to the surfaces of objects via chemical, mechanical, thermal, thermo-mechanical, chemical vapor deposition, physical vapor deposition and vacuum deposition or by dipping processes in a solution

[ Sanitary products for medicine, namely, sanitary preparations for medical use; ] antibacterial, biocidal, virucidal and antimicrobial sprays; anti-inflammatory sprays; [ medicinal preparations for the mouth, nose and ears as sprays; antiseptic sprays in the form of aerosols for the skin; antiseptic sprays in aerosol form for hard surfaces; sterilizing solutions, namely, sterilizing preparations; sanitary products for sterilization; ] biocidal, bactericidal, virucidal, microbicidal, germicidal solutions; anti-inflammatory solutions; [ antibacterial preparations in the nature of antibacterial soap, antimicrobial preparations for inhibiting and killing bacteria, and antiviral preparations; ] anti-inflammatory preparations; [ disinfectants; antiseptics; biocides; germicides; antiviral agents, namely, antiviral disinfectants and antiviral coatings to treat the growth of viruses on various surfaces; antibacterial products for washing hands, namely, antibacterial hand soaps; antiseptic preparations for the treatment of wounds; articles for dressings, materials for dressing wounds, liquid dressings for skin wounds, namely, medical and surgical dressings, sterilized dressings, self-adhesive dressings, and wound dressings; disinfectants for hygienic use; disinfectant impregnated wipes for sanitary use; bath preparations for medical use; ] chemical preparations for medical or veterinary use, namely, for treating viral, bacteriological and fungal infections; biological preparations for the treatment of viral, bacteriological and fungal infections; [ amino acids for medical or veterinary use; biological tissue cultures for medical use; cultures of microorganisms for medical or veterinary use; lining materials for dental use; ] biocides in the nature of antibacterial, antimicrobial and antiviral coatings for preventing and treating the development of viruses, microbes and bacteria on various surfaces; all the aforesaid goods being for medical, surgical, dental or veterinary use

Filing History

INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Mar 26, 2026 INNA
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Oct 5, 2025 INPR
FINAL DECISION TRANSACTION PROCESSED BY IB
May 9, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Apr 22, 2025 FICS
FINAL DISPOSITION PROCESSED
Apr 22, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 26, 2025 FICR
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
Feb 25, 2025 NURC
LIMITATION FROM THE IB EXAMINED AND ENTERED
Feb 5, 2025 LIME
LIMITATION FROM THE IB EXAMINED AND ENTERED
Feb 5, 2025 LIME
CORRECTION UNDER SECTION 7 - PROCESSED
Feb 5, 2025 COC.
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Feb 5, 2025 APRE
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Feb 4, 2025 LIMN
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Feb 4, 2025 CORN
LIMITATION OF GOODS RECEIVED FROM IB
Nov 29, 2024 LIMG
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Nov 26, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Nov 26, 2024 R.PR
CORRECTION TRANSACTION RECEIVED FROM IB
Nov 15, 2024 CRCV
LIMITATION OF GOODS RECEIVED FROM IB
Nov 15, 2024 LIMG
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Nov 3, 2024 ETOP
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Sep 20, 2024 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 4, 2024 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Sep 4, 2024 OPNR
LIMITATION OF GOODS RECEIVED FROM IB
Aug 17, 2024 LIMG
EXTENSION OF TIME TO OPPOSE RECEIVED
Jul 24, 2024 ETOF
NOTIFICATION PROCESSED BY IB
Jul 1, 2024 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 25, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jun 25, 2024 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 11, 2024 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jun 11, 2024 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 5, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 17, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
May 15, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 15, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
May 15, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 15, 2024 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 18, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 18, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 18, 2024 TROA
REFUSAL PROCESSED BY IB
Nov 22, 2023 RFNP
CHANGE OF NAME/ADDRESS REC'D FROM IB
Nov 5, 2023 ADCH
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 2, 2023 RFCS
REFUSAL PROCESSED BY MPU
Nov 2, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 2, 2023 RFCR
NON-FINAL ACTION WRITTEN
Nov 1, 2023 CNRT
ASSIGNED TO EXAMINER
Oct 26, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Apr 22, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 18, 2023 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Apr 17, 2023 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 7, 2023 REPR